70,002 Shares in Ultralife Co. (NASDAQ:ULBI) Acquired by Raymond James Financial Inc.

Raymond James Financial Inc. purchased a new stake in shares of Ultralife Co. (NASDAQ:ULBI - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 70,002 shares of the technology company's stock, valued at approximately $522,000. Raymond James Financial Inc. owned approximately 0.42% of Ultralife at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of ULBI. Janney Montgomery Scott LLC boosted its stake in shares of Ultralife by 0.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 447,000 shares of the technology company's stock worth $3,330,000 after acquiring an additional 3,850 shares during the period. Renaissance Technologies LLC raised its holdings in shares of Ultralife by 11.6% during the 4th quarter. Renaissance Technologies LLC now owns 256,090 shares of the technology company's stock worth $1,908,000 after acquiring an additional 26,700 shares in the last quarter. Geode Capital Management LLC increased its position in Ultralife by 1.2% in the third quarter. Geode Capital Management LLC now owns 232,681 shares of the technology company's stock worth $2,104,000 after purchasing an additional 2,835 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its stake in Ultralife by 13.2% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 178,170 shares of the technology company's stock valued at $1,327,000 after purchasing an additional 20,840 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in Ultralife by 45.3% during the fourth quarter. JPMorgan Chase & Co. now owns 68,952 shares of the technology company's stock valued at $514,000 after purchasing an additional 21,494 shares during the last quarter. Hedge funds and other institutional investors own 30.68% of the company's stock.

Ultralife Trading Down 1.4%

ULBI traded down $0.08 during trading on Wednesday, reaching $5.45. The company had a trading volume of 17,098 shares, compared to its average volume of 70,334. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The business has a 50 day simple moving average of $4.93 and a 200-day simple moving average of $6.65. The stock has a market cap of $90.57 million, a P/E ratio of 9.90 and a beta of 0.77. Ultralife Co. has a 52 week low of $4.07 and a 52 week high of $12.40.

Ultralife (NASDAQ:ULBI - Get Free Report) last issued its earnings results on Friday, May 9th. The technology company reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.02). The firm had revenue of $50.75 million for the quarter, compared to the consensus estimate of $54.50 million. Ultralife had a net margin of 5.44% and a return on equity of 7.92%. During the same period last year, the firm earned $0.21 earnings per share.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of Ultralife from a "hold" rating to a "buy" rating in a research report on Monday.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.